4-methylthioamphetamine has been researched along with citalopram in 3 studies
Studies (4-methylthioamphetamine) | Trials (4-methylthioamphetamine) | Recent Studies (post-2010) (4-methylthioamphetamine) | Studies (citalopram) | Trials (citalopram) | Recent Studies (post-2010) (citalopram) |
---|---|---|---|---|---|
38 | 0 | 9 | 5,348 | 1,424 | 2,350 |
Protein | Taxonomy | 4-methylthioamphetamine (IC50) | citalopram (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.297 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.196 | |
Aromatase | Rattus norvegicus (Norway rat) | 0.0018 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.196 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.289 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.297 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0227 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.0027 | |
Histamine H1 receptor | Homo sapiens (human) | 3.194 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.839 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1869 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.398 | |
Transporter | Rattus norvegicus (Norway rat) | 8.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Butler, SG; Cloonan, SM; Corrigan, D; Jørgensen, AM; Keating, JJ; Knox, AJ; Lloyd, DG; Meegan, MJ; Peters, GH; Rai, D; Williams, DC | 1 |
Butler, SG; Cloonan, SM; Keating, JJ; Knox, AJ; McNamara, YM; Meegan, MJ; Peters, GH; Williams, DC | 1 |
Ceglia, I; Gobbi, M; Mennini, T; Moia, M; Pirona, L; Reyes-Parada, M; Scorza, C | 1 |
3 other study(ies) available for 4-methylthioamphetamine and citalopram
Article | Year |
---|---|
Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.
Topics: Amphetamines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Phenethylamines; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Sulfur | 2009 |
Synthesis and serotonin transporter activity of 1,3-bis(aryl)-2-nitro-1-propenes as a new class of anticancer agents.
Topics: Alkenes; Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Molecular Structure; Nitro Compounds; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2011 |
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
Topics: Amphetamines; Animals; Binding, Competitive; Brain Chemistry; Carrier Proteins; Citalopram; Dose-Response Relationship, Drug; Hippocampus; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Nerve Tissue Proteins; p-Chloroamphetamine; Piperazines; Rats; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Tritium | 2002 |